Literature DB >> 36157282

Pathways to Phage Therapy Enlightenment, or Why I Have Become a Scientific Curmudgeon.

Stephen T Abedon1.   

Abstract

Over the past decade I, with collaborators, have authored a number of publications outlining what in the first of these I described as "Phage therapy best practices"-phage therapy being the use of bacterial viruses (bacteriophages) to treat bacterial infections, such as clinically. More generally, this is phage-mediated biocontrol of bacteria, including of bacteria that can contaminate foods. For the sake of increasing accessibility, here I gather some of these suggestions, along with some frustrations, into a single place, while first providing by way of explanation where they, and I, come from scientifically. Although in my opinion phage therapy and phage-mediated biocontrol are both sound approaches toward combating unwanted bacteria, I feel at the same time that the practice of especially phage therapy research could be improved. I supply also, as supplemental material, a list of ∼100 English language 2000-and-later publications providing primary descriptions of phage application to humans. Copyright 2022, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  antibacterial; antibiotic; bacteriophage therapy; biological control

Year:  2022        PMID: 36157282      PMCID: PMC9436250          DOI: 10.1089/phage.2022.0012

Source DB:  PubMed          Journal:  Phage (New Rochelle)        ISSN: 2641-6530


  19 in total

1.  Bacteriophage prehistory: Is or is not Hankin, 1896, a phage reference?

Authors:  Stephen T Abedon; Cameron Thomas-Abedon; Anne Thomas; Hubert Mazure
Journal:  Bacteriophage       Date:  2011-05-01

Review 2.  Bacteriophage host range and bacterial resistance.

Authors:  Paul Hyman; Stephen T Abedon
Journal:  Adv Appl Microbiol       Date:  2010-03-06       Impact factor: 5.086

Review 3.  Phage therapy pharmacology.

Authors:  Stephen T Abedon; Cameron Thomas-Abedon
Journal:  Curr Pharm Biotechnol       Date:  2010-01       Impact factor: 2.837

4.  Active bacteriophage biocontrol and therapy on sub-millimeter scales towards removal of unwanted bacteria from foods and microbiomes.

Authors:  Stephen T Abedon
Journal:  AIMS Microbiol       Date:  2017-08-04

Review 5.  Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?

Authors:  Stephen T Abedon
Journal:  Antibiotics (Basel)       Date:  2019-10-11

6.  Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth.

Authors:  Stephen T Abedon; Katarzyna M Danis-Wlodarczyk; Daniel J Wozniak
Journal:  Pharmaceuticals (Basel)       Date:  2021-10-03

Review 7.  Look Who's Talking: T-Even Phage Lysis Inhibition, the Granddaddy of Virus-Virus Intercellular Communication Research.

Authors:  Stephen T Abedon
Journal:  Viruses       Date:  2019-10-16       Impact factor: 5.048

8.  Improving Phage-Biofilm In Vitro Experimentation.

Authors:  Stephen T Abedon; Katarzyna M Danis-Wlodarczyk; Daniel J Wozniak; Matthew B Sullivan
Journal:  Viruses       Date:  2021-06-19       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.